AGED Diagnostics
Founded in 2018, AGED Diagnostics is a team of geneticists and hepatologists dedicated to translating genomic innovation into clinical tools. They are developing the most accurate blood test for liver disease, specifically nonalcoholic steatohepatitis (NASH), aiming to improve early detection, intervention, and patient outcomes. Their mission is to leverage genomic technology to provide noninvasive, precise diagnostics for liver diseases, reducing reliance on invasive biopsies and improving healthcare efficiency.
Industries
Nr. of Employees
small (1-50)
Products
In-development blood-based diagnostic test for liver disease (NASH) and fibrosis staging
A noninvasive blood test in development that uses targeted genomic sequencing to quantify circulating biomarkers and provide diagnostic classification (distinguish NASH from simple steatosis) and fibrosis staging.
In-development blood-based diagnostic test for liver disease (NASH) and fibrosis staging
A noninvasive blood test in development that uses targeted genomic sequencing to quantify circulating biomarkers and provide diagnostic classification (distinguish NASH from simple steatosis) and fibrosis staging.
Services
Data processing and interpretation services for targeted sequencing and spatial transcriptomics to support biomarker discovery and diagnostic development.
Execution of laboratory workflows for targeted genomic assays and sample processing under laboratory operations leadership.
Collaborative support with clinical investigators and hepatology specialists for study design, sample access, and translational research integration.
Data processing and interpretation services for targeted sequencing and spatial transcriptomics to support biomarker discovery and diagnostic development.
Execution of laboratory workflows for targeted genomic assays and sample processing under laboratory operations leadership.
Collaborative support with clinical investigators and hepatology specialists for study design, sample access, and translational research integration.
Expertise Areas
- Biomarker discovery
- Molecular diagnostics development
- Spatial transcriptomics
- Epigenetics applied to liver disease
Key Technologies
- Targeted genomic sequencing
- Spatial transcriptomics
- DNA methylation assays
- miRNA and non-coding RNA profiling
News & Updates
Recognition as a top fundable startup, positioning the company for future capital raises and market leadership.
An article discussing the role of epigenetics in liver disease development and potential therapeutic targets.
Awarded for being a highly fundable startup among thousands of applicants.
Won first place in a competition judged by life science executives and investors, and presented at the CBA Annual Symposium.
Recognition as a top fundable startup, positioning the company for future capital raises and market leadership.
An article discussing the role of epigenetics in liver disease development and potential therapeutic targets.
Awarded for being a highly fundable startup among thousands of applicants.
Won first place in a competition judged by life science executives and investors, and presented at the CBA Annual Symposium.